Nature Biotechnology’s Irene Jarchum speaks with Michel Sadelain about off-the-shelf CAR-T cells, and discusses a recent paper from Maksim Mamonkin’s group describing a clever strategy to mitigate CAR-T cell rejection. The paper was published in
Nature Biotechnology and can be read
here.
Hosted on Acast. See acast.com/privacy for more information.
